This article covers more than one peptide, or peptides in general. Regulatory status differs from one peptide to the next and changes over time; each peptide's specific status is noted in the content below.
Status as of July 6, 2026
The defining job of a peptide in the body is communication. These short chains of amino acids act mostly as signaling molecules, carrying instructions between cells, tissues, and organs, and a large share of the body's hormones, including insulin, glucagon, growth hormone, and oxytocin, are peptides. Because they are smaller and shorter-lived than full proteins, peptides function as precise, fast-acting messengers rather than the bulky structural or catalytic workhorses that proteins tend to be.
A large share of the body's hormones, including insulin, glucagon, growth hormone, oxytocin, and gut hormones, are peptides, which is why the molecule's central role in the body is signaling rather than structure.
A peptide hormone is a chemical messenger that lets one part of the body instruct another, secreted by endocrine cells and released into the blood or local tissue to reach its targets. The biology behind their speed comes from their chemistry: peptides are water-soluble and cannot pass through the fatty cell membrane, so they bind receptors on the cell surface, trigger second messengers inside, and are then cleared quickly by enzymes.
| Property | Peptide hormones | Steroid hormones |
|---|---|---|
| Solubility | Water-soluble | Fat-soluble |
| Receptor site | Cell surface | Inside the cell |
| Speed of effect | Rapid | Slower |
| Mechanism | Second messengers | Changes gene expression |
Because peptide hormones are water-soluble and bind surface receptors that trigger second messengers, they act quickly and reversibly, in contrast to fat-soluble steroid hormones that enter cells and act more slowly by changing gene expression.
Metabolism and appetite are regulated by a network of peptides that constantly report the body's energy status to the brain and digestive organs. Ghrelin rises before meals and signals hunger, while peptide YY, cholecystokinin, and the incretin GLP-1 are released after eating and promote fullness, forming a gut-brain axis that adjusts eating behavior and energy expenditure. The reported clinical relevance is direct: blunted incretin response and impaired insulin signaling are features of type 2 diabetes.
The incretins GLP-1 and GIP stimulate insulin release in response to food and slow stomach emptying to smooth post-meal glucose spikes, and a blunted incretin response is one of the documented features of type 2 diabetes.
Antimicrobial peptides are a frontline part of the innate immune system, produced by epithelial cells lining the skin, gut, and airways and by white blood cells such as neutrophils, positioned exactly where pathogens first try to enter. Their primary mechanism is physical disruption rather than a learned response, which is what lets them act broadly and within minutes.
Because antimicrobial peptides such as defensins and cathelicidins attack a structural membrane feature shared by many microbes rather than a single specific target, resistance is generally harder to develop than against conventional antibiotics, though it is not impossible and remains under active study.
Structural strength is usually the domain of full proteins, not short peptides, yet peptides sit at the foundation of that structure. Every structural protein, from the collagen in skin, tendons, and bone to the keratin in hair and nails, is built from amino acids joined by peptide bonds, so the peptide bond itself is the chemical link holding these long chains together. Short peptides on their own rarely provide mechanical strength, because structural support depends on long, folded, often cross-linked chains.
Structural support in tissues depends on long, folded, and often cross-linked protein chains rather than short peptides, but the peptide bond is the chemical link that holds those structural chains together.
The body makes peptides through two main routes and dismantles them just as deliberately, which is what gives peptide signals their short, tightly controlled lifespan. Most are built directly on ribosomes, while others are cut out of a larger precursor protein by specific enzymes, the route that produces insulin from a trimmed prohormone. Once a peptide has done its job, peptidases break the bonds and return the chain to reusable amino acids.
Most signaling peptides have a deliberately short half-life measured in minutes because peptidases and proteases continuously break their bonds, ensuring a signal stops once it is no longer needed.
Most peptides act by docking onto receptors, and the location of those receptors shapes the whole process. Since peptides are water-soluble and cannot easily cross the fatty membrane, their receptors usually sit on the cell surface, often as G protein-coupled receptors, and binding changes the receptor's shape to transmit the signal inward without the peptide ever entering the cell. This is the source of peptide signaling's precision: a circulating peptide reaches every tissue, but only cells carrying the matching receptor react.
A cell responds only to peptides for which it carries the matching surface receptor, so the same circulating peptide can prompt different responses in different cells depending on the receptors each one carries.
When peptide signaling falls out of balance, the disruption ripples through whatever process that peptide controls, and it can come from too little of a peptide, too much, or a breakdown in how the signal is received. Insulin is the clearest documented case: when cells stop responding properly or the pancreas cannot make enough, blood sugar regulation fails and diabetes results, showing how a single disrupted pathway can drive a major chronic condition.
Peptide signaling can fail even when the peptide level is normal, because reduced, mutated, or unresponsive receptors produce an inadequate response, which is the documented hallmark of resistance states such as insulin resistance.
The functional split between peptides and proteins follows from their size and stability. Peptides are short chains that often do not adopt a rigid permanent fold, which suits them to quick, disposable messaging, while proteins are long chains that fold into stable three-dimensional shapes to do demanding work such as catalysis, structure, and transport. The boundary is a matter of convention rather than a sharp biological wall.
| Trait | Peptides | Proteins |
|---|---|---|
| Length | Short chains, up to a few dozen amino acids | Long chains |
| Structure | Often no rigid permanent fold | Complex stable 3D fold |
| Main role | Quick, disposable signaling | Catalysis, structure, transport |
| Lifespan | Minutes | Often far longer |
The distinction between peptide and protein is a matter of convention, with chains roughly up to a few dozen amino acids called peptides and longer ones called proteins, and the functional reality is that small short-lived peptides specialize in communication while large folded proteins do the structural and catalytic heavy lifting.
Educational use only. This article describes what the published scientific and clinical literature reports about Peptides. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
